ACADIA PHARMACEUTICALS INC·4

Aug 13, 6:05 PM ET

Thompson Elizabeth H.Z. 4

4 · ACADIA PHARMACEUTICALS INC · Filed Aug 13, 2024

Insider Transaction Report

Form 4
Period: 2024-08-12
Thompson Elizabeth H.Z.
EVP, Head of Research & Dev
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-08-12+324,582324,582 total
    Exercise: $15.29Exp: 2034-08-11Common Stock (324,582 underlying)
  • Award

    Restricted Stock Units

    2024-08-12+64,54464,544 total
    Common Stock (64,544 underlying)
Footnotes (3)
  • [F1]25% of the shares subject to the Stock Option will vest and become exercisable on July 29, 2025. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
  • [F3]50% of the restricted stock units vest on July 29, 2026 and 25% vest on each of July 29, 2027 and July 29, 2028.

Documents

1 file
  • 4
    form4-08132024_060801.xmlPrimary